These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12554734)

  • 1. Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.
    Gu B; Johnston VK; Gutshall LL; Nguyen TT; Gontarek RR; Darcy MG; Tedesco R; Dhanak D; Duffy KJ; Kao CC; Sarisky RT
    J Biol Chem; 2003 May; 278(19):16602-7. PubMed ID: 12554734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
    Dhanak D; Duffy KJ; Johnston VK; Lin-Goerke J; Darcy M; Shaw AN; Gu B; Silverman C; Gates AT; Nonnemacher MR; Earnshaw DL; Casper DJ; Kaura A; Baker A; Greenwood C; Gutshall LL; Maley D; DelVecchio A; Macarron R; Hofmann GA; Alnoah Z; Cheng HY; Chan G; Khandekar S; Keenan RM; Sarisky RT
    J Biol Chem; 2002 Oct; 277(41):38322-7. PubMed ID: 12167642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase.
    Eltahla AA; Lackovic K; Marquis C; Eden JS; White PA
    J Biomol Screen; 2013 Oct; 18(9):1027-34. PubMed ID: 23708123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepatitis C virus core protein can modulate RNA-dependent RNA synthesis by the 2a polymerase.
    Wen Y; Cheng Kao C
    Virus Res; 2014 Aug; 189():165-76. PubMed ID: 24874198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophobic and charged residues in the C-terminal arm of hepatitis C virus RNA-dependent RNA polymerase regulate initiation and elongation.
    Cherry AL; Dennis CA; Baron A; Eisele LE; Thommes PA; Jaeger J
    J Virol; 2015 Feb; 89(4):2052-63. PubMed ID: 25428878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of de novo-initiated RNA synthesis in hepatitis C virus RNA-dependent RNA polymerase by intermolecular interactions.
    Chinnaswamy S; Murali A; Li P; Fujisaki K; Kao CC
    J Virol; 2010 Jun; 84(12):5923-35. PubMed ID: 20375156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance profile of a hepatitis C virus RNA-dependent RNA polymerase benzothiadiazine inhibitor.
    Nguyen TT; Gates AT; Gutshall LL; Johnston VK; Gu B; Duffy KJ; Sarisky RT
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3525-30. PubMed ID: 14576112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo initiation pocket mutations have multiple effects on hepatitis C virus RNA-dependent RNA polymerase activities.
    Ranjith-Kumar CT; Sarisky RT; Gutshall L; Thomson M; Kao CC
    J Virol; 2004 Nov; 78(22):12207-17. PubMed ID: 15507607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of de novo initiation by the hepatitis C virus RNA-dependent RNA polymerase: role of divalent metals.
    Ranjith-Kumar CT; Kim YC; Gutshall L; Silverman C; Khandekar S; Sarisky RT; Kao CC
    J Virol; 2002 Dec; 76(24):12513-25. PubMed ID: 12438577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound.
    Madhvi A; Hingane S; Srivastav R; Joshi N; Subramani C; Muthumohan R; Khasa R; Varshney S; Kalia M; Vrati S; Surjit M; Ranjith-Kumar CT
    Sci Rep; 2017 Jul; 7(1):5816. PubMed ID: 28725041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.
    Zhou S; Liu R; Baroudy BM; Malcolm BA; Reyes GR
    Virology; 2003 Jun; 310(2):333-42. PubMed ID: 12781720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA.
    Ahn DG; Shim SB; Moon JE; Kim JH; Kim SJ; Oh JW
    J Viral Hepat; 2011 Jul; 18(7):e298-306. PubMed ID: 21692941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic activities of the GB virus-B RNA-dependent RNA polymerase.
    Ranjith-Kumar CT; Santos JL; Gutshall LL; Johnston VK; Lin-Goerke J; Kim MJ; Porter DJ; Maley D; Greenwood C; Earnshaw DL; Baker A; Gu B; Silverman C; Sarisky RT; Kao C
    Virology; 2003 Aug; 312(2):270-80. PubMed ID: 12919733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dinucleotide analogues as novel inhibitors of RNA-dependent RNA polymerase of hepatitis C Virus.
    Zhong W; An H; Barawkar D; Hong Z
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2674-81. PubMed ID: 12878540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic profile of a heterocyclic HCV replicon RNA synthesis inhibitor.
    Johnston VK; Maley D; Gagnon RC; Grassmann CW; Behrens SE; Sarisky RT
    Biochem Biophys Res Commun; 2003 Nov; 311(3):672-7. PubMed ID: 14623324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner.
    Weng L; Hirata Y; Arai M; Kohara M; Wakita T; Watashi K; Shimotohno K; He Y; Zhong J; Toyoda T
    J Virol; 2010 Nov; 84(22):11761-70. PubMed ID: 20844041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro.
    Weng L; Tian X; Gao Y; Watashi K; Shimotohno K; Wakita T; Kohara M; Toyoda T
    Biochim Biophys Acta; 2012 Dec; 1820(12):1886-92. PubMed ID: 22954804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of RNA binding by the hepatitis C virus RNA-dependent RNA polymerase.
    Kim YC; Russell WK; Ranjith-Kumar CT; Thomson M; Russell DH; Kao CC
    J Biol Chem; 2005 Nov; 280(45):38011-9. PubMed ID: 16166071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.
    Bellecave P; Cazenave C; Rumi J; Staedel C; Cosnefroy O; Andreola ML; Ventura M; Tarrago-Litvak L; Astier-Gin T
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2097-110. PubMed ID: 18347106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV RdRp, sofosbuvir and beyond.
    Feng JY; Ray AS
    Enzymes; 2021; 49():63-82. PubMed ID: 34696839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.